Abstract
Hemorrhagic fever with renal syndrome (HFRS) and Crimean-Congo hemorrhagic fever (CCHF) are common representatives of viral hemorrhagic fevers still often neglected in some parts of the world. Infection with Dobrava or Puumala virus (HFRS) and Crimean-Congo hemorrhagic fever virus (CCHFV) can result in a mild, nonspecific febrile illness or as a severe disease with hemorrhaging and high fatality rate. An important factor in optimizing survival rate in patients with VHF is instant recognition of the severe form of the disease for which significant biomarkers need to be elucidated. To determine the prognostic value of High Mobility Group Box 1 (HMGB1) as a biomarker for disease severity, we tested acute serum samples of patients with HFRS or CCHF. Our results showed that HMGB1 levels are increased in patients with CCHFV, DOBV or PUUV infection. Above that, concentration of HMGB1 is higher in patients with severe disease progression when compared to the mild clinical course of the disease. Our results indicate that HMGB1 could be a useful prognostic biomarker for disease severity in PUUV and CCHFV infection, where the difference between the mild and severe patients group was highly significant. Even in patients with severe DOBV infection concentrations of HMGB1 were 2.8–times higher than in the mild group, but the difference was not statistically significant. Our results indicated HMGB1 as a potential biomarker for severe hemorrhagic fevers.
Highlights
Viral hemorrhagic fevers (VHFs) are characterized by a severe multisystem syndrome and are caused by viruses from several different families
In this study we investigated the role of High Mobility Group Box 1 (HMGB1) as a prognostic marker for the severe form of Hemorrhagic fever with renal syndrome (HFRS) and Crimean-Congo hemorrhagic fever (CCHF)
Patients with severe Puumala virus (PUUV) infection had the highest concentration of HMGB1, infection with Dobrava virus (DOBV) and CrimeanCongo Hemorrhagic fever virus (CCHFV) usually causes more severe hemorrhagic manifestations
Summary
Viral hemorrhagic fevers (VHFs) are characterized by a severe multisystem syndrome and are caused by viruses from several different families. Hantaviruses and CrimeanCongo Hemorrhagic fever virus (CCHFV), members of the Bunyaviridae family, represent important causative agents of VHFs. Hantaviruses are present globally and each hantavirus is closely related to a specific rodent or insectivore natural host. In Slovenia, both severe and mild clinical courses of the disease have been observed, with an overall case fatality rate of 4.5% [1,2]. CCHFV is the causative agent of Crimean-Congo hemorrhagic fever (CCHF), which is the most widespread tick-borne viral infection. The course of the disease can be extremely severe, with hemorrhaging and case fatality rate between 3% and 30%. To HFRS, CCHF can result in a mild, nonspecific febrile illness or an asymptomatic infection [4]
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.